T. Rowe Price Associates »

Travere Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $253k 28k 9.02
2023-09-30 $240k 27k 8.94
2023-06-30 $571k 37k 15.37
2023-03-31 $704k 31k 22.50
2022-12-31 $610k 29k 21.04
2022-03-31 $425k 17k 25.78
2021-12-31 $441k 14k 31.06